In Ewing sarcoma, ROR1 expression was markedly higher in metastases than in localized disease [70], and in pancreatic cancer, ROR1 was identified on circulating tumor cells (CTCs) as an essential factor for their invasive phenotype [63]. This evidence concerns the gene ROR1 and Ewing sarcoma.